IRIS Accounts Production v24.3.0.553 11152125 director 1.2.23 31.1.24 31.1.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh111521252023-01-31111521252024-01-31111521252023-02-012024-01-31111521252022-09-30111521252022-10-012023-01-31111521252023-01-3111152125ns15:EnglandWales2023-02-012024-01-3111152125ns14:PoundSterling2023-02-012024-01-3111152125ns10:Director12023-02-012024-01-3111152125ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3111152125ns10:SmallEntities2023-02-012024-01-3111152125ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3111152125ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3111152125ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3111152125ns10:FullAccounts2023-02-012024-01-311115212512023-02-012024-01-3111152125ns10:RegisteredOffice2023-02-012024-01-3111152125ns5:CurrentFinancialInstruments2024-01-3111152125ns5:CurrentFinancialInstruments2023-01-3111152125ns5:Non-currentFinancialInstruments2024-01-3111152125ns5:Non-currentFinancialInstruments2023-01-3111152125ns5:ShareCapital2024-01-3111152125ns5:ShareCapital2023-01-3111152125ns5:RevaluationReserve2024-01-3111152125ns5:RevaluationReserve2023-01-3111152125ns5:RetainedEarningsAccumulatedLosses2024-01-3111152125ns5:RetainedEarningsAccumulatedLosses2023-01-3111152125ns5:NetGoodwill2023-02-012024-01-3111152125ns5:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3111152125ns5:LandBuildings2023-02-012024-01-3111152125ns5:PlantMachinery2023-02-012024-01-3111152125ns5:NetGoodwill2023-01-3111152125ns5:NetGoodwill2024-01-3111152125ns5:NetGoodwill2023-01-3111152125ns5:LandBuildings2023-01-3111152125ns5:PlantMachinery2023-01-3111152125ns5:LandBuildings2024-01-3111152125ns5:PlantMachinery2024-01-3111152125ns5:LandBuildings2023-01-3111152125ns5:PlantMachinery2023-01-3111152125ns5:CostValuation2023-01-3111152125ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3111152125ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3111152125ns5:Secured2024-01-3111152125ns5:Secured2023-01-3111152125ns5:RevaluationReserve2023-01-31
REGISTERED NUMBER: 11152125 (England and Wales)















Financial Statements for the Year Ended 31st January 2024

for

Kent Equine Hospital Limited

Kent Equine Hospital Limited (Registered number: 11152125)

Contents of the Financial Statements
for the year ended 31st January 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Kent Equine Hospital Limited

Company Information
for the year ended 31st January 2024







DIRECTOR: Ms K L Snalune





REGISTERED OFFICE: Eastfield Barn
Hucking
Maidstone
Kent
ME17 1QX





REGISTERED NUMBER: 11152125 (England and Wales)





ACCOUNTANTS: Beak Kemmenoe
Chartered Accountants
1-3 Manor Road
Chatham
Kent
ME4 6AE

Kent Equine Hospital Limited (Registered number: 11152125)

Balance Sheet
31st January 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 12,907 18,527
Tangible assets 5 1,625,108 800,065
Investments 6 243,590 243,590
1,881,605 1,062,182

CURRENT ASSETS
Stocks 30,000 26,119
Debtors 7 55,236 49,362
Cash at bank and in hand 100 31
85,336 75,512
CREDITORS
Amounts falling due within one year 8 1,919,894 709,795
NET CURRENT LIABILITIES (1,834,558 ) (634,283 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

47,047

427,899

CREDITORS
Amounts falling due after more than one
year

9

(120,038

)

(265,140

)

PROVISIONS FOR LIABILITIES - (13,397 )
NET (LIABILITIES)/ASSETS (72,991 ) 149,362

CAPITAL AND RESERVES
Called up share capital 10 10
Revaluation reserve 11 50,717 50,717
Retained earnings (123,718 ) 98,635
SHAREHOLDERS' FUNDS (72,991 ) 149,362

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Kent Equine Hospital Limited (Registered number: 11152125)

Balance Sheet - continued
31st January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 13th October 2024 and were signed by:





Ms K L Snalune - Director


Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements
for the year ended 31st January 2024


1. STATUTORY INFORMATION

Kent Equine Hospital Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Preparation of consolidated financial statements
The financial statements contain information about Kent Equine Hospital Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of eight years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 10% on reducing balance
Plant and machinery etc - 25% on reducing balance

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements - continued
for the year ended 31st January 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 15 (2023 - 12 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1st February 2023
and 31st January 2024 44,960
AMORTISATION
At 1st February 2023 26,433
Charge for year 5,620
At 31st January 2024 32,053
NET BOOK VALUE
At 31st January 2024 12,907
At 31st January 2023 18,527

Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements - continued
for the year ended 31st January 2024


5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST OR VALUATION
At 1st February 2023 708,825 204,384 913,209
Additions 759,941 192,344 952,285
At 31st January 2024 1,468,766 396,728 1,865,494
DEPRECIATION
At 1st February 2023 - 113,144 113,144
Charge for year 56,346 70,896 127,242
At 31st January 2024 56,346 184,040 240,386
NET BOOK VALUE
At 31st January 2024 1,412,420 212,688 1,625,108
At 31st January 2023 708,825 91,240 800,065

Cost or valuation at 31st January 2024 is represented by:

Plant and
Land and machinery
buildings etc Totals
£    £    £   
Valuation in 2001 50,717 - 50,717
Cost 1,418,049 396,728 1,814,777
1,468,766 396,728 1,865,494

If freehold land and buildings had not been revalued they would have been included at the following historical cost:

2024 2023
£    £   
Cost 658,108 658,108

Value of land in freehold land and buildings 180,000 180,000

Freehold land and buildings were valued on an open market basis on 31st January 2023 by the director .

Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements - continued
for the year ended 31st January 2024


6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1st February 2023
and 31st January 2024 243,590
NET BOOK VALUE
At 31st January 2024 243,590
At 31st January 2023 243,590

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 33,371 24,121
Other debtors 21,865 25,241
55,236 49,362

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 181,627 199,117
Hire purchase contracts 22,923 26,865
Trade creditors 105,407 157,798
Taxation and social security 37,943 16,429
Other creditors 1,571,994 309,586
1,919,894 709,795

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 78,355 241,515
Hire purchase contracts 41,683 23,625
120,038 265,140

Kent Equine Hospital Limited (Registered number: 11152125)

Notes to the Financial Statements - continued
for the year ended 31st January 2024


10. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£    £   
Bank loans 193,466 400,259
Hire purchase contracts 64,606 50,490
258,072 450,749

Assets held on hire purchase are secured on the assets concerned.

Metro Bank PLC has a fixed and floating charge over all property or undertaking of the company.

The Director has given a personal guarantee to Metro Bank PLC.

11. RESERVES
Revaluation
reserve
£   
At 1st February 2023
and 31st January 2024 50,717